Two Sigma Investments »

Travere Therapeutics shares owned by Two Sigma Investments

Quarter-by-quarter ownership of Travere Therapeutics shares owned by Two Sigma Investments from 13F filings

Historical chart of Two Sigma Investments investment in Travere Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Travere Therapeutics held by Two Sigma Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Travere Therapeutics by Two Sigma Investments

Quarter filed Position value Share count Share price at filing
2026-03-31 $3.8M 3.0M 1.26

More positions owned by Two Sigma Investments

NVIDIA Corporation (NVDA)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Tesla Motors (TSLA)
JPMorgan Chase & Co. (JPM)
Palantir Technologies Cl A (PLTR)
Costco Wholesale Corporation (COST)
TJX Companies (TJX)
Mastercard Incorporated Cl A (MA)
Metropcs Communications (TMUS)
Lockheed Martin Corporation (LMT)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Micron Technology (MU)
Adobe Systems Incorporated (ADBE)

View all positions for Two Sigma Investments

Top funds holding Travere Therapeutics

Linden Advisors
Context Capital Management
D. E. Shaw & Co
Tenor Capital Management
FMR
Advent Capital Management
Graham Capital Management
Shenkman Capital Management
Lord, Abbett & Co
Affinity Asset Advisors
M&G
BlackRock
Henderson Group
Goldman Sachs Group
Two Sigma Investments

View all funds holding Travere Therapeutics